Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Equibles does not estimate personal net worth.
Biocryst Pharmaceuticals Inc reported in an 8-K filed September 14, 2022 that Ryan Arnold was appointed Chief Medical Officer, effective September 15, 2022. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.
“Also effective September 15, 2022, Dr. Ryan Arnold will serve as the Company's new Chief Medical Officer.”
Source not stated
Drug Manufacturers - Specialty & Generic · Healthcare